Article
Inhibition of Bruton’s Tyrosine Kinase Alleviates Monocrotaline-Induced Pulmonary Arterial…
Oxidative Medicine and Cellular Longevity · 2021 · Min Yu, author Xuecheng Wu, author Liyao Peng, author Mingxia Yang, author Hong Zhou, author Jian Xu, author Jingjing Wang, author Hong Wang, author Weiping Xie, author Hui Kong, author Ying Han, Academic Editor
Key facts
| Title | Inhibition of Bruton’s Tyrosine Kinase Alleviates Monocrotaline-Induced Pulmonary Arterial Hypertension by Modulating Macrophage Polarization |
|---|---|
| First author | Min Yu, author Xuecheng Wu, author Liyao Peng, author Mingxia Yang, author Hong Zhou, author Jian Xu, author Jingjing Wang, author Hong Wang, author Weiping Xie, author Hui Kong, author Ying Han, Academic Editor |
| Journal | Oxidative Medicine and Cellular Longevity |
| Published | Oct 28, 2021 |
| DOI | 10.1155/2022/6526036 |
| Product codes mentioned | GIA |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1